Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramkhamhaeng Hospital PCL's quarterly cash, cash equivalents, marketable securities
declined
from Dec. 2025 (฿2,719.06 Mil) to Mar. 2026 (฿2,568.79 Mil) but then
stayed the same
from Mar. 2026 (฿2,568.79 Mil) to Jun. 2026 (฿2,543.28 Mil).
Ramkhamhaeng Hospital PCL's annual cash, cash equivalents, marketable securities
declined
from Dec. 2023 (฿1,295.97 Mil) to Dec. 2024 (฿1,093.91 Mil) but then
increased
from Dec. 2024 (฿1,093.91 Mil) to Dec. 2025 (฿2,719.06 Mil).
Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
A high number means either:
1) The company has competitive advantage generating lots of cash
2) Just sold a business or bonds (not necessarily good)
A low stockpile of cash usually means poor to mediocre economics.
There are 3 ways to create large cash reserve.
1) Sell new bonds or equity to public
2) Sell business or asset
3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)
When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.
Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.
Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.
Ramkhamhaeng Hospital PCL Cash, Cash Equivalents, Marketable Securities Related Terms
Ramkhamhaeng Hospital PCL Cash, Cash Equivalents, Marketable Securities Historical Data
* Premium members only.
The historical data trend for Ramkhamhaeng Hospital PCL's Cash, Cash Equivalents, Marketable Securities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.
What does a Cash, Cash Equivalents, Marketable Securities of ฿2,543 Mil mean?
Ramkhamhaeng Hospital PCL (BKK:RAM-R) has a Cash, Cash Equivalents, Marketable Securities of ฿2,543 Mil as of Jun. 2026. The total cash, cash equivalents and marketable securities a company has on hand. View historical data on Ramkhamhaeng Hospital PCL and its competitors.
Is Ramkhamhaeng Hospital PCL's Cash, Cash Equivalents, Marketable Securities too high?
Ramkhamhaeng Hospital PCL's current Cash, Cash Equivalents, Marketable Securities is ฿2,543 Mil. Overall, Ramkhamhaeng Hospital PCL has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Ramkhamhaeng Hospital PCL's Cash, Cash Equivalents, Marketable Securities compare to HCA and THC?
Ramkhamhaeng Hospital PCL's Cash, Cash Equivalents, Marketable Securities of ฿2,543 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash, Cash Equivalents, Marketable Securities for a Healthcare Providers & Services company?
A good Cash, Cash Equivalents, Marketable Securities depends on the Healthcare Providers & Services industry context. However, Cash, Cash Equivalents, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash, Cash Equivalents, Marketable Securities mean?
A high Cash, Cash Equivalents, Marketable Securities can signal that a stock is expensive relative to its fundamentals. The total cash, cash equivalents and marketable securities a company has on hand. View historical data on Ramkhamhaeng Hospital PCL and its competitors. Ramkhamhaeng Hospital PCL's current Cash, Cash Equivalents, Marketable Securities is ฿2,543 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramkhamhaeng Hospital PCL stock overvalued right now?
Ramkhamhaeng Hospital PCL (BKK:RAM-R) has a current Cash, Cash Equivalents, Marketable Securities of ฿2,543 Mil. The stock's GF Value™ is ฿42.29, compared to a current price of ฿17.40 — trading 58.9% below its estimated fair value. The current Cash, Cash Equivalents, Marketable Securities is ฿2,543 Mil. Ramkhamhaeng Hospital PCL's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash, Cash Equivalents, Marketable Securities calculated?
Cash, Cash Equivalents, Marketable Securities is calculated from a company's financial statements. For Ramkhamhaeng Hospital PCL (BKK:RAM-R), the current Cash, Cash Equivalents, Marketable Securities is ฿2,543 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramkhamhaeng Hospital PCL (BKK:RAM-R) Overvalued in 2026?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL stock appears to be undervalued.
The current stock price of ฿17.40 is trading 58.9% below its estimated GF Value™ of ฿42.29.
Key valuation signals for BKK:RAM-R:
Cash, Cash Equivalents, Marketable Securities: ฿2,543 Mil
GF Value™: ฿42.29 vs. price of ฿17.40 (58.9% below fair value)
No single metric tells the full story. See the BKK:RAM-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramkhamhaeng Hospital PCL business activities are hospital and businesses that support medical care. The company provides medical treatment for all types of diseases by physicians and medical professionals in all specialties. Its medical services include the 24-hour Heart Center, RAM Pituitary Center for laparoscopic surgery for pituitary tumors, Neurology & Neurosurgery Center, and specialized medical centers such as Eye Clinic, Ear, Nose and Throat Clinic, Gastroenterology Clinic, Obstetrics and Gynecology Clinic, and Diabetes Clinic. The company operates through two segments: Hospital, which includes General Hospital and Hospital in Social Security and generates the maximum revenue; and Others, which includes sale of medical equipment and instruments. Its operations are in Thailand.
73GF Score
Get the complete analysis for BKK:RAM-R
Cash, Cash Equivalents, Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:RAM-R has been successfully added to your 
